labiotech: Next-generation small molecules hold promise for immunotherapy Media CoverageBy Gwen SchankerFebruary 1, 2023...
Scrip Asks: What Does 2023 Hold For Biopharma? Part 2: M&A And Partnering Media CoverageBy Gwen SchankerJanuary 9, 2023...
BioSpace: Executives Reunite at JPM as Biotech Kicks Off 2023 Media CoverageBy Gwen SchankerJanuary 5, 2023...
Scrip Asks: What Does 2023 Hold For Biopharma? Part 1: The Funding Environment Media CoverageBy Gwen SchankerJanuary 4, 2023...
Life Science Leader: 2023 Finance And Funding Outlook: Additional Insights Part 1 Media CoverageBy Gwen SchankerDecember 2, 2022...
BioSpace: Recession Survival Strategies for Newly Public Biopharma Companies Media CoverageBy Gwen SchankerNovember 28, 2022...
Clinical Leader: Portage Biotech Creates A New Drug Development Model Media CoverageBy Gwen SchankerNovember 21, 2022...
Target Cancer Podcast: Train our immune system to kill cancer and prevent recurrence Media CoverageBy Gwen SchankerNovember 14, 2022...
Pharma’s Almanac Roundtable: What is your plan to build a more sustainable business practice in the coming years? Media CoverageBy Gwen SchankerOctober 11, 2022...